Showing results (71-80 of 77) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
Clinical Endocrinology|April 17, 2023
Association of B7H3 and B7H4 gene polymorphisms and protein expression with the development and prognosis of autoimmune thyroid diseasesHaruka Ozaki, Naoya Inoue, Yoshinori Iwatani, et al.Autoimmunity|November 27, 2018
Polymorphisms in Th17-related genes and the pathogenesis of autoimmune thyroid diseaseTakayuki Kunisato, Mikio Watanabe, Naoya Inoue, et al.Biology Open|August 9, 2021
Arf GTPase-activating proteins SMAP1 and AGFG2 regulate the size of Weibel-Palade bodies and exocytosis of von Willebrand factorAsano Watanabe, Hikari Hataida, Naoya Inoue, et al.Japanese Journal of Clinical Oncology|April 12, 2022
Phase I/II study of streptozocin monotherapy in Japanese patients with unresectable or metastatic gastroenteropancreatic neuroendocrine tumorsIzumi Komoto, Norihiro Kokudo, Taku Aoki, et al.Cancer Chemotherapy and Pharmacology|September 3, 2010
A multi-institution phase II study of gemcitabine/S-1 combination chemotherapy for patients with advanced biliary tract cancerMasashi Kanai, Kenichi Yoshimura, Takehiko Tsumura, et al.Journal of Hepato-Biliary-Pancreatic Sciences|May 1, 2015
Conversion to complete resection with mFOLFOX6 with bevacizumab or cetuximab based on K-ras status for unresectable colorectal liver metastasis (BECK study)Etsuro Hatano, Masayuki Okuno, Kojiro Nakamura, et al.Journal of Hepato-Biliary-Pancreatic Sciences|May 4, 2020
Conversion to complete resection with mFOLFOX6 with bevacizumab or cetuximab based on K-RAS status for unresectable colorectal liver metastasis (BECK study): Long-term results of survivalMasayuki Okuno, Etsuro Hatano, Rei Toda, et al.Pageof 8